Table 3 Comparison of general data and laboratory indices between the treatment and control groups after the intervention
Treatment group (n = 30) | Control group (n = 30) | ||||
|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | z-value | t-value | p-value | |
Drainage volume (mL) | 332.33 (131.98) | 447.00 (178.46) | – | −2.83 | 0.006* |
Maximum VAS (cm) | 3.07 (1.20) | 4.00 (1.13) | −3.26 | – | 0.001* |
WBC1 (10^9/L) | 12.78 (3.21) | 12.60 (2.99) | – | 0.223 | 0.825 |
RBC1 (10^9/L) | 4.02 (0.70) | 3.76 (0.49) | – | 1.656 | 0.103 |
Hb1 (g/L) | 119.10 (15.17) | 116.1 (14.38) | – | 0.786 | 0.435 |
ESR1 (mm/h) | 13.97 (8.59) | 12.80 (10.67) | – | 0.466 | 0.643 |
CRP1 (mg/L) | 24.20 (16.81) | 32.35 (18.77) | – | −1.771 | 0.082 |
WBC3 (10^9/L) | 10.83 (2.76) | 10.20 (2.27) | – | 0.964 | 0.339 |
RBC3 (10^9/L) | 3.84 (0.50) | 3.46 (0.53) | – | 2.896 | 0.005* |
Hb3 (g/L) | 116.77 (13.54) | 107.1 (15.99) | – | 2.527 | 0.014* |
ESR3 (mm/h) | 32.30 (22.65) | 34.73 (26.96) | – | −0.378 | 0.706 |
CRP3 (mg/L) | 44.06 (48.64) | 60.23 (51.43) | – | −1.251 | 0.216 |
WBC10 (10^9/L) | 8.48 (1.77) | 7.57 (2.38) | – | 1.676 | 0.099 |
RBC10 (10^9/L) | 5.68 (2.27) | 4.66 (1.54) | – | 2.040 | 0.047* |
Hb10 (g/L) | 120.37 (14.77) | 109.53 (22.26) | – | 2.221 | 0.030* |
ESR10 (mm/h) | 34.90 (20.01) | 34.59 (22.31) | – | 0.056 | 0.955 |
CRP10 (10^9/L) | 13.87 (11.24) | 23.14 (19.30) | – | −2.273 | 0.028* |